NYU Langone Hospital Receives $250K from Cutting-Edge Alzheimer’s Disease Research
NYU’s Langone Hospital—Long Island just received a $250,000 grant from the Alzheimer’s Foundation of America (AFA) to expand and accelerate […]
Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor
Eli Lilly and Co inked a deal to gain worldwide, exclusive licensing rights to the autoimmune and inflammatory disease treatment […]
Apple Watch Can Help Identify & Track Parkinson’s Disease Symptoms Based on New Study Results
With a growing array of smart applications, ubiquitous cloud compute infrastructure and Big Data, new forms of remote clinical research […]
Jazz Pharmaceuticals Accesses First Approved Cannabidiol-based Medicine & Pipeline with $7.2b Acquisition of GW Pharmaceuticals Plc
Ireland-domiciled Jazz Pharmaceutical is apparently sold as the first developer of what is the first and only U.S. Food and […]
Dr. Ian Smith And Stuart Young Talk About Lessons From Covid-19: Strategy For Recruiting Patients
An Interview with Dr. Ian Smith, Founder, Director and Chief Medical Officer of Panthera Biopartners and CEO of Panthera […]
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Secures $4.6m for Two Studies Investigating Lenalidomide in Early State Alzheimer’s Patients
The National Institute of Aging (NIA), part of the National Institutes of health (NIH) and the Alzheimer’s Drug Discovery Foundation […]
ADAPT-2 Study Results: Although Low, Overall Response Drug Combo May Help Some Meth Addicts
Although much attention has focused on the opioid epidemic, a parallel methamphetamine crisis rages on while the COVID-19 pandemic continues […]
University of Buffalo Investigator Receives $3.1m from NIH to Investigate Impact of DBS on Parkinson’s Patients
Patients with Parkinson’s disease who are treated with deep brain stimulation (DBS) generally have unpredictable and varied speech outcomes after […]
Biogen & Apple Announce Virtual Study Involving Cognitive Decline Nationwide
Biogen recently announced a new digitally-powered virtual study in partnership with Apple to identify digital biomarkers to help monitor cognitive […]
UC Riverside Serves As Lead Investigational Site for Study Evaluating Ecopipam for Adults Who Stutter
The School of Medicine at the University of California, Riverside (UC Riverside) will serve as lead investigational site for a […]
